Law360, New York (January 17, 2008, 12:00 AM ET) -- An appellate court has dismissed CytoLogix Corp.'s appeal of a lower court's decision to combine its patent infringement and antitrust lawsuits against Ventana Medical Systems Inc. in the same trial over cancer diagnostic methods through tissue analysis.
The U.S. Court of Appeals for the First Circuit on Thursday dismissed CytoLogix's appeal because it involved claims under patent law, which are under the exclusive appellate jurisdiction of the U.S. Court of Appeals for the Federal Circuit.
The First Circuit said it would have transferred the appeal, but...
1st Circ. Won't Hear CytoLogix's Patent Claims
To view the full article, take a free trial now.
